Evidence method
Level · gp.fundamentals.debt_to_revenue
131.70% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
ABEO · Jun 30, 2026
ABEONA THERAPEUTICS INC.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 1[email protected]
Inspectable configuration
State dimensions
Filing0001493152-26-037576General Corporate
Evidence method
Level · gp.fundamentals.capex_revenue_ratio
4.21% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-153.74% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
2745.00% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
52.03% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.gross_margin
63.30% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
-119.97% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
44.12% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
29.60% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History3 statesHistory building
Period transition
What moved in the state?
- Previous
- 207.42%
- Current
- 131.70%
- Delta
- -75.72%
- Previous
- 10.72%
- Current
- 4.21%
- Delta
- -6.51%
- Previous
- -227.11%
- Current
- -153.74%
- Delta
- 73.37%
- Previous
- 69.43%
- Current
- 52.03%
- Delta
- -17.40%
- Previous
- 69.08%
- Current
- 63.30%
- Delta
- -5.79%
- Previous
- -264.14%
- Current
- -119.97%
- Delta
- 144.17%
- Previous
- 109.58%
- Current
- 44.12%
- Delta
- -65.45%
- Previous
- 33.91%
- Current
- 29.60%
- Delta
- -4.31%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Compared To · Pharmaceutical Preparations peers →Has State · ABEONA THERAPEUTICS INC. →Transitioned To · ABEO Fundamental State →Transitioned To · ABEO BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · ABEO CAPEX_INTENSITY_DECREASED →Transitioned To · ABEO CASH_GENERATION_INCREASED →Transitioned To · ABEO INVENTORY_PRESSURE_DECREASED →Transitioned To · ABEO MARGIN_DECREASED →Transitioned To · ABEO PROFITABILITY_INCREASED →Transitioned To · ABEO R_AND_D_INTENSITY_DECREASED →Transitioned To · ABEO SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.